NHS to use robots on obese patients during surgery as it's safest way to operate on them
ROBO DOC NHS to use robots on obese patients during surgery as it's safest way to operate on them
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
THE NHS will use surgical robots to get more fat Brits on the operating table because machines can work on people who are too high-risk for manual procedures.
They use smaller instruments and enter through smaller incisions, and can be faster so patients do not need as much anaesthetic.
Sign up for Scottish Sun
newsletter
Sign up
3
Staff using the new Versius robotic arm technology during a surgery at Milton Keynes NHS Hospital
Credit: PA
3
Robotics is one of the Government's 'five big bets' on technology that will revolutionise the NHS
Robotics is one of the Government's 'five big bets' on technology that will revolutionise the NHS.
Ministers' 10-Year Plan for the health service, launched last week, said it will 'expand surgical robot adoption'.
NHS watchdog the National Institute for Health and Care Excellence (Nice) has encouraged hospitals to invest more in surgical robots and use them more widely.
A recent report by NHS England added: 'Robot-assisted surgery may improve access to surgery for people who are at higher risk, including people with a high body mass index.'
Body mass index is a height-to-weight ratio, with any number higher than 30 classed as obese.
About three in 10 adults in England are obese and this puts them at higher risk during operations and may even mean they can't have them.
Bulky fat means it takes longer to conduct super-precise surgery and large patients need more anaesthetic and lose more blood.
Top prostate surgeon Ben Challacombe, who works at Guy's and St Thomas' NHS Trust in London, said: 'Operating on obese patients is highly complex and more tricky.
'When you're obese you're much more likely to get an infection or to have breathing difficulties because your lungs are being squashed by other tissues.
'Robotic assistance means we can do more.
Robot doctor that can perform surgery in space is destined for ISS
'We can do robotic surgery on much bigger patients than we could with traditional keyhole surgery.'
Jeffrey Ahmed, a gynaecological surgeon at Chelsea and Westminster NHS Trust, said: 'Some patients are too obese to have an operation, because to do a big open operation on someone whose BMI is 65 subjects them to too much risk.
'The minimally invasive approach that we can do on the robot opens up the possibility of doing that kind of care for patients.
'I think it will be used more in the future.
'If you can't physically do an operation for a patient without a robot, then that's going to be the way to do it.
'You can't just not offer the patient surgery because you don't have access to a robot.'
Robot-assisted surgery relies on qualified surgeons controlling the £1m machines with the usual medical team around the patient.
There are about 140 machines in use in England and their use has rocketed from 35,000 operations in 2022 to 70,000 in 2024.
Dr Chris Smith-Brown, from the Private Healthcare Information Network, added: 'We know that losing weight is not always possible.
'There is hope that obesity won't have to be a barrier to life-changing surgery.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Powys County Times
10 minutes ago
- Powys County Times
Medicine shortages put patients at risk, MPs and peers warn
Patients are facing serious harm from persistent and widespread medicine shortages, MPs and peers have warned. A new report from the All-Party Parliamentary Group (APPG) on pharmacy called for urgent action to ensure shortages do not become the 'new normal'. It also highlights the impact that shortages are having on patients with the likes of ADHD (attention deficit hyperactivity disorder), menopause and diabetes. Writing in the report, Steve Race, chairman of the APPG on pharmacy, said many MPs 'have received a growing volume of correspondence from constituents who are understandably anxious about the availability of their medicines'. 'Whether it is a parent unable to access antibiotics for a sick child, an elderly patient facing delays in obtaining life-sustaining medication, or a pharmacist overwhelmed by the need to source alternatives, the human impact is both visible and deeply troubling,' he wrote. The report said that while medicine shortages are 'not a new phenomenon', they have 'become increasingly severe, persistent, and disruptive' in recent years – leading to consequences for patients, staff and the wider health service. Mr Race said: 'Medicines shortages have moved from isolated incidents to a chronic structural challenge for both the NHS and pharmacy sector. 'As Government continues to recognise and invest in the expanded clinical role of community pharmacy, we must ensure the medicines supply chain underpinning that care is equally robust, resilient and patient-focused. 'Pharmacy is central to NHS recovery and transformation, but frontline teams cannot safely expand clinical services while daily supply disruptions continue to impact the health of patients.' The findings also highlight how shortages severely impact patients with conditions like ADHD, menopause and diabetes. More than nine in 10 pharmacists, GPs and prescribers told an APPG survey ADHD medicines had been affected by shortages. Around three quarters (76%) said HRT and diabetes drugs had been affected, while 44% said antibiotics. One patient with ADHD told the inquiry they had been self-medicating with cannabis due to an ongoing shortage of methylphenidate. The report said: 'These shortages are having a significant impact on patients' ability to access treatments and in some cases are having serious impact on patients' health and well-being.' Mr Race added: 'Medicines security must be treated as a core component of NHS planning, alongside funding, workforce and digital infrastructure. 'Failure to act risks further undermining patient care and destabilising a community pharmacy sector that millions depend upon.' The APPG has laid out a number of recommendations, which includes a number of measures to better support patients. People impacted by shortages, particularly those with chronic conditions, struggle to find information on out of stock drugs, leading to 'frustration, dangerous delays in care, and unnecessary anxiety and harm', it said. It also welcomed work being carried out by the Department of Health and Social Care to potentially change pharmacist prescribing protocols to allow pharmacists to make dose and formulation changes during shortages. Elsewhere, the inquiry found more than eight in 10 pharmacists face daily shortages, with many spending hours every day finding alternative treatment and communicating with distressed patients. One told the APPG they are 'constantly firefighting'. Reacting to the report, Henry Gregg, chief executive of the National Pharmacy Association (NPA), said: 'Pharmacy teams are under enormous pressure but are forced to spend hours hunting down stock for distressed and frustrated patients. 'It is particularly frustrating for pharmacists to be unable to meet a clear need when they have a perfectly safe and effective solution in their pharmacy already. 'MPs are right that it is madness to send someone back to their GP to get a prescription changed, and it risks a patient either delaying taking vital medication or forgoing it altogether, which poses a clear risk to patient safety. 'As the APPG says, the Government must allow pharmacists – who are highly trained health care practitioners – to use their professional judgment to supply an appropriate alternative medication when the prescribed version is unavailable.' A Department of Health and Social Care spokesperson said: 'This government inherited ongoing global supply problems, but we have robust measures in place to mitigate disruption for patients. 'We are working to build the resilience of medicine supply chains and prevent future disruption as we get the NHS back on its feet. 'We have recently agreed an extra £617 million of funding over two years with Community Pharmacy England to support the sector and provide patients with more services closer to home as part of our 10 Year Health Plan.'
Powys County Times
10 minutes ago
- Powys County Times
‘Groundbreaking' drug could slow down progression of type 1 diabetes
A 'groundbreaking' drug to slow down the development of type 1 diabetes is being tried by a handful of patients in the UK. Teplizumab, which is already approved in the US, trains the immune system to stop attacking pancreatic cells, delaying the need for insulin by an average of three years. With type 1 diabetes, the immune system attacks insulin-producing cells in the pancreas, meaning blood sugar levels are no longer regulated by the body. If blood sugar is too high or low, it can cause serious health problems and even death. People with type 1 therefore need daily insulin. Dentist and mother-of-two, Hannah Robinson, from Devon, is the first adult in the UK to try the drug in the hope it can delay the condition. She is having treatment at the Royal Devon University Healthcare NHS Foundation Trust after discovering during pregnancy she was in the early stages of developing type 1. A handful of people are being given the medicine on a case-by-case basis while it is reviewed for wider use on the NHS. The 36-year-old said: 'For me, this new drug offers more freedom and the chance to focus on my health before I have to start thinking differently and managing life as somebody needing daily insulin. 'This isn't just about what I eat or monitoring my glucose, it is also about having more control and not feeling defined by my condition. 'This treatment could potentially pave the way for a future cure for type 1 diabetes, which is incredible. I feel very lucky to be part of this.' The new drug teplizumab must be given at the earliest stage of the disease to be effective. Dr Nick Thomas, diabetes consultant and academic clinical lecturer at the University of Exeter, said: 'This new treatment represents a really exciting shift in how we manage type 1 diabetes. 'For the first time ever, we will be able to provide targeted treatment early enough in the process to alter the underlying immune process, aiming to slow down how quickly people need insulin. 'Approximately half of all type 1 diabetes cases develop in adulthood, and Hannah will be the first adult in the UK to receive this treatment. 'My hope is that in the future, we may be able to stop people with early type 1 diabetes from needing insulin at all.' Experts at the Royal Devon and the University of Exeter are using genetics and other testing to spot people at high risk of developing type 1 diabetes. The hope is more people could be offered the drug to delay type 1. Dr Lucy Chambers, head of research impact and communications at Diabetes UK, said: 'For people in the early stages of type 1 diabetes, teplizumab offers a groundbreaking opportunity to buy them precious extra years insulin-free. 'Right now, it's only available in research settings – and while the excitement is real, urgent work is still needed to ensure it reaches everyone who could benefit. 'That means securing a UK licence for teplizumab, establishing national screening programmes to identify people with early-stage type 1 diabetes before symptoms appear, and preparing the NHS to deliver this treatment at scale. 'Diabetes UK is proud to be at the forefront of these efforts – funding pioneering research and working closely with the NHS towards a future where immunotherapies become the first-line treatment for tackling the autoimmune attack at the root of type 1 diabetes.' Professor Richard Oram, consultant physician at the Royal Devon and professor at the University of Exeter, said: 'Excitingly, teplizumab is the first drug with the potential to delay type 1 diabetes, but needs to be given before clinical diagnosis due to high blood glucose. 'It is really important to find new and improved approaches for identifying individuals at elevated risk.'
Daily Mirror
2 hours ago
- Daily Mirror
Met Office urges Brits to follow 4 rules in extreme heat this week
Heatwave thresholds are set to be met this week with millions of Brits urged to follow four strict rules to stay safe in the boiling mercury Britain is set to be plunged into another heatwave in just hours as the mercury is set to skyrocket yet again. The Met Office has confirmed that temperatures could climb into the low 30Cs again by the end of this week. Deputy chief meteorologist Dan Holley said: 'High pressure from the Atlantic will gradually exert its influence over the UK this week. We'll see temperatures build day-on-day, with the potential for hot conditions to become quite widespread by the end of the week and into the weekend." When heatwave thresholds are met, the forecaster urges Brits to follow a set of guidelines for safety in the heat. These include daylight hours to swerve if you're negatively impacted by the heat, to watching over neighbours who could be vulnerable in such conditions. One of their core rules is to avoid the sun at its strongest, which is 11am to 3pm. How mixing sunny days and alcoholic beverages can take a toll on your health The Met Office coupled with the UKHSA said in its guidance: 'The heat can affect your health and make you feel unwell, there are many simple things you can do to keep yourself safe.' Brits are to bring water with them wherever they go, as well as wear sunscreen protection. A wide-brimmed hat is strongly recommended for extra protection. Drinking plenty of fluids is important to keep hydrated in hot temperatures. When it's hot, the body sweats to cool down and naturally loses fluids. Drinking water is key, IU Health said. As many Brits use public transport to get around, this is crucial, especially during rush hour, when trains and buses tend to be extra packed with people trying to get home. For those who love to spend time outdoors exercising or enjoy the weather, it's best to avoid doing so between 11am and 3pm, when the sun is the strongest. If you decide to go out for the sunshine, SPF protection is a must. The higher, the better. Last but not least, close the curtains in rooms that face the sun if you're going to be out of the house for a long time. Why? Because the sun can radiate through the windows, making your home hotter than it needs to be. By closing the curtains, your house remains cooler. It's also helpful if you have any pets at home, to prevent them from feeling uncomfortable and in worst cases, getting heatstroke. When will the heatwave end? While the mercury is set to creep up to heatwave levels by this weekend, there are signs, according to the Met Office, that things will begin to cool down by early next week. "Exactly how quickly this transfers eastwards is uncertain," the Met Office said. "It's certainly possible that hot conditions may persist for a while longer, especially towards the south and east."
